| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13181* | 2021 |
| Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC K Quint, A Agaimy, P Di Fazio, R Montalbano, C Steindorf, R Jung, ... Virchows Archiv 459, 129-139, 2011 | 136 | 2011 |
| SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib S Emanuele, M Lauricella, D Carlisi, B Vassallo, A D’Anneo, P Di Fazio, ... Apoptosis 12, 1327-1338, 2007 | 123 | 2007 |
| Dual anticancer activity in a single compound: visible-light-induced apoptosis by an antiangiogenic iridium complex A Kastl, A Wilbuer, AL Merkel, L Feng, P Di Fazio, M Ocker, E Meggers Chemical communications 48 (13), 1863-1865, 2012 | 117 | 2012 |
| Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition K Quint, M Tonigold, P Di Fazio, R Montalbano, S Lingelbach, F Rueckert, ... International journal of oncology 41 (6), 2093-2102, 2012 | 106 | 2012 |
| The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation D Carlisi, M Lauricella, A D’Anneo, S Emanuele, L Angileri, P Di Fazio, ... European journal of cancer 45 (13), 2425-2438, 2009 | 98 | 2009 |
| Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines P Di Fazio, R Montalbano, D Neureiter, B Alinger, A Schmidt, AL Merkel, ... Experimental cell research 318 (15), 1832-1843, 2012 | 85 | 2012 |
| The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis P Di Fazio, R Schneider-Stock, D Neureiter, K Okamoto, T Wissniowski, ... Analytical Cellular Pathology 32 (4), 285-300, 2010 | 75 | 2010 |
| DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions M Gandesiri, S Chakilam, J Ivanovska, N Benderska, M Ocker, P Di Fazio, ... Apoptosis 17, 1300-1315, 2012 | 71 | 2012 |
| Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation B Behm, P Di Fazio, P Michl, D Neureiter, R Kemmerling, EG Hahn, ... Gut 65 (1), 134-143, 2016 | 62 | 2016 |
| Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects D Carlisi, B Vassallo, M Lauricella, S Emanuele, A D'Anneo, ... International journal of oncology 32 (1), 177-184, 2008 | 57 | 2008 |
| Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome E Klieser, R Urbas, S Stättner, F Primavesi, T Jäger, A Dinnewitzer, ... Human pathology 65, 41-52, 2017 | 56 | 2017 |
| Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines S Zopf, M Ocker, D Neureiter, B Alinger, S Gahr, MF Neurath, P Di Fazio Bmc Cancer 12, 1-10, 2012 | 50 | 2012 |
| The crosstalk of miRNA and oxidative stress in the liver: from physiology to pathology and clinical implications E Klieser, C Mayr, T Kiesslich, T Wissniowski, P Di Fazio, D Neureiter, ... International journal of molecular sciences 20 (21), 5266, 2019 | 47 | 2019 |
| Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer P Di Fazio, P Waldegger, S Jabari, S Lingelbach, R Montalbano, M Ocker, ... Oncotarget 7 (20), 28998, 2016 | 47 | 2016 |
| The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells C Mayr, A Wagner, M Loeffelberger, D Bruckner, M Jakab, F Berr, ... Oncotarget 7 (1), 745, 2016 | 46 | 2016 |
| MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5 AI Damanakis, S Eckhardt, A Wunderlich, S Roth, TT Wissniowski, ... Journal of cancer research and clinical oncology 142, 1213-1220, 2016 | 45 | 2016 |
| Pharmacological inhibition of class IIA HDACs by LMK-235 in pancreatic neuroendocrine tumor cells J Wanek, M Gaisberger, M Beyreis, C Mayr, K Helm, F Primavesi, T Jäger, ... International journal of molecular sciences 19 (10), 3128, 2018 | 44 | 2018 |
| AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors CR Gloesenkamp, B Nitzsche, M Ocker, P Di Fazio, K Quint, B Hoffmann, ... International journal of oncology 40 (3), 876-888, 2012 | 44 | 2012 |
| Expression of hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors of the lung P Di Fazio, M Maass, S Roth, C Meyer, J Grups, P Rexin, DK Bartsch, ... Tumor Biology 39 (10), 1010428317728417, 2017 | 43 | 2017 |
Thorsten StieweVerified email at staff.uni-marburg.de
